14 completed, 2 unknown, 1 terminated. 8 Phase 3, 4 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Unknown 1 |
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Hugel: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of 'BRFS-18G-S100WH' as Compared to 'MINT Lift FINE+' in Subject With Nasolabial Folds BRFS-18G-S100WH, MINT Lift FINE+ - Nasolabial Folds | Not applicable | Unknown | Hugel | 106 | 2024-02-29 | 2024-01-22 |
| Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox] - Glabellar Lines | Phase 3 | Unknown | Hugel | 272 | 2024-01-04 | 2024-01-16 |
| To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines. Botulinum Toxin Type A Injection [Botox], Botulinum toxin type A injection [HG-102] - Glabellar Lines | Phase 1 | Completed | Hugel | 38 | 2021-06-11 | 2022-05-24 |
| Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines Botulinum toxin A "BoNT/A-DP", Botulinum toxin A "Botox Cosmetics" - Frown Lines | Phase 2 | Completed | Croma-Pharma GmbH | 208 | 2020-06-24 | 2025-03-18 |
| Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy Botulinum Toxin Type A Injection (Botulax®) 24Units, Botulinum Toxin Type A Injection (Botulax®) 48Units, Botulinum Toxin Type A Injection (Botulax®) 72Units - Benign Masseteric Hypertrophy | Phase 2 | Completed | Hugel | 80 | 2020-05-27 | 2021-11-16 |
| Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia Botulinum toxin type A injection, Botulinum Toxin Type A Injection [Botox] - Cervical Dystonia | Phase 1 | Completed | Hugel | 38 | 2020-05-26 | 2022-04-22 |
| Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder Botulinum toxin type A injection, Botulinum Toxin Type A Injection [Botox] - Overactive Bladder | Phase 1 | Completed | Hugel | 38 | 2020-05-12 | 2022-04-15 |
| the Hypertrophic Scar Prevention of BMT101. BMT101 - Hypertrophic Scar | Phase 2 | Terminated | Hugel | 20 | 2019-08-21 | 2023-05-24 |
| Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines Botulinum toxin type A - Crow's Feet Lines | Phase 3 | Completed | Hugel | 240 | 2018-01-17 | 2022-04-15 |
| Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers BMT101, Placebo - Hypertrophic Scar | Phase 1 | Completed | Hugel | 32 | 2017-07-31 | 2018-04-25 |
| Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines. Botulinum Toxin A type for injection (Botulax®), Botulinum Toxin A type for injection (BOTOX®, Bao Tuo Shi®) - Glabellar Lines | Phase 3 | Completed | Hugel | 500 | 2017-05-09 | 2022-05-24 |
| A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement Volus/Powerfill - Penile Enhancement | Phase 3 | Completed | Hugel | 68 | 2015-06-01 | 2017-08-08 |
| The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm. Botulinum toxin type A - Essential Blepharospasm | Phase 4 | Completed | Hugel | 249 | 2015-04-30 | 2018-08-22 |
| Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity Botulinum toxin type A(Botulax®), Botulinum toxin type A(Botox®) - Stroke, Spasticity | Phase 3 | Completed | Hugel | 186 | 2013-06-01 | 2015-05-04 |
| Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral Palsy Botulinum Toxin Type A(Botox®), Botulinum toxin type A(Botulax®) - Other Infantile Cerebral Palsy | Phase 3 | Completed | Hugel | 144 | 2012-03-01 | 2015-05-04 |
| To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines Botulinum toxin type A(Botulax®), Botulinum toxin type A(Botox®) - Skin Aging | Phase 3 | Completed | Hugel | 262 | 2011-08-01 | 2022-04-15 |
| Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm Hugeltox, Botulinum Toxin Type A(Botox®) - Essential Blepharospasm | Phase 3 | Completed | Hugel | 172 | 2008-04-01 | 2013-02-15 |
Benign essential blepharospasm (2) · Cicatrix (2) · Cicatrix, Hypertrophic (2) · Muscle Spasticity (1) · Stroke (1) · Torticollis (1) · Urinary Bladder, Overactive (1)
Botulinum Toxins, Type A (12) · Injections (1) · Saline Solution (1)
South Korea (16) · Austria (1) · Canada (1) · United States (1)
Jeong-yi Kwon, M.D., Ph.D. (1) · Min-ho Chun, Ph.D. (1) · Yoon-Duck Kim, M.D., Ph.D. (1)